MEIP Key Stats
- 4 Stocks Under $10 Triggering Breakouts The Street 03/07 03:00 ET
- Midday movers: EBay, Madison Square Garden & More Yahoo 02/28 12:00 ET
- MEI Pharma (MEIP) Announces Orphan Status for Pracinostat Street Insider 02/28 08:40 ET
- 8:36 am MEI Pharma confirmed that the U.S. Food and Drug Administration has granted orphan drug designation to the Co's investigational drug Pracinostat for the treatment of acute myeloid leukemia Yahoo 02/28 08:36 ET
- MEI Pharma Receives Orphan Status For Lead Drug Candidate Pracinostat For Treatment Of Acute Myeloid Leukemia PR Newswire 02/28 08:33 ET
- MEI Pharma acute myeloid leulemia treatment gets FDA orhpan designation Yahoo 02/27 19:11 ET
- MEI Pharma To Present At Cowen Health Care And ROTH Conferences PR Newswire 02/25 09:00 ET
- MEI PHARMA, INC. Files SEC form 10-Q, Quarterly Report Yahoo 02/11 16:45 ET
- 5 Stocks Ready to Break Out The Street 01/31 09:01 ET
- 4 Biotech Stocks Under $10 Making Big Moves The Street 01/29 02:00 ET
MEIP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MEI Pharma is up 18.93% over the last year vs S&P 500 Total Return up 24.37%, Eisai down 10.47%, and Horizon Pharma up 538.5%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for MEIP
Pro Strategies Featuring MEIP
Did MEI Pharma make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
MEI Pharma Inc is a development-stage oncology company engaged in the clinical development of novel small molecules for the treatment of cancer.